National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 1339534

Government Disclaimer on use of this data



Case Details

VAERS ID: 1339534 (history)  
Form: Version 2.0  
Age: 89.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-16
Onset:2021-05-18
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EX3617 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Acute myocardial infarction, Body temperature, Computerised tomogram
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CILOSTAZOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210516; Test Name: body temperature; Result Unstructured Data: Test Result:36.7 Centigrade; Comments: Before vaccination; Test Date: 20210518; Test Name: CT; Result Unstructured Data: Test Result:suspected myocardial infarction; Comments: (only findings of severe pulmonary congestion)
CDC Split Type: JPPFIZER INC2021563636

Write-up: Acute myocardial infarction; This is a spontaneous report from a contactable physician, medical examiner. This is a report received from the Regulatory Authority (RA). Regulatory authority report number is v21107059. An 89-year-old female patient received the first dose of the bnt162b2 (COMIRNATY; Lot Number: EX3617; Expiration Date: 31Aug2021), via an unspecified route of administration on 16May2021 at 09:15 at a single dose for covid-19 immunisation. The medical history included hypertension. Concomitant medication included cilostazol (CILOSTAZOL). On 18May2021 at 01:00, the patient experienced acute myocardial infarction, which was serious for death. On 16May2021 at 09:15 (the day of vaccination), the patient received the first dose of BNT162b2. On 17May2021 (one day after vaccination), until at night, the patient led a normal life. On 18May2021 around 01:00 (2 days after the vaccination), the patient experienced acute myocardial infarction. On 18May2021 at 06:30, the patient was found to collapse to the floor of the bedroom, and she was confirmed to be dead. The patient underwent lab tests and procedures which included body temperature: 36.7 degrees Centigrade on 16May2021 before vaccination, computerised tomogram: strongly suspected myocardial infarction (only findings of severe pulmonary congestion) on 18May2021. The patient died on 18May2021 due to acute myocardial infarction. It was not reported if an autopsy was performed. The reporting physician classified the event as serious (death) and assessed that the causality between the event and bnt162b2 as unassessable. Other possible cause of the event such as any other diseases was hypertension. REPORTER COMMENT: The causal relationship between the event and BNT162b2 was unknown according to the patient''s age and underlying disease. No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Acute myocardial infarction


New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=1339534


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166